Mycobacteria and immunosuppression

Kevin L. Winthrop, Emilie Emilie Roy

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Mycobacterial infections are complex diseases and are even more in individuals suffering from immune-mediated inflammatory diseases (IMIDs). They can cause tuberculosis, nontuberculous mycobacteria (NTM) pulmonary infections, other localized NTM or disseminated infections, leprosy, and chronic ulcers (Buruli ulcer). IMID-afflicted patients are at increased risk, often have atypical clinical presentations and unusual or complicated clinical courses during therapy. Providers taking care of individuals with IMID must have some knowledge about mycobacterial infections to recognize and diagnose the disease. They should not treat those infections alone and should look for expert guidance. Treatment usually implies multiple drugs that can cause severe side effects. This hazard can be reduced with judicious selection of therapeutic agents and close monitoring. Prevention of disease acquisition, reactivation, and recurrence should also be sought.

Original languageEnglish (US)
Title of host publicationHandbook of Systemic Autoimmune Diseases
PublisherElsevier Ltd
Pages83-107
Number of pages25
DOIs
StatePublished - 2020

Publication series

NameHandbook of Systemic Autoimmune Diseases
Volume16
ISSN (Print)1571-5078

Keywords

  • Buruli ulcer
  • Leprosy
  • MAC
  • Mycobacteria
  • Mycobacterium
  • Mycobacterium avium complex
  • Nontuberculous mycobacteria
  • Tuberculosis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Mycobacteria and immunosuppression'. Together they form a unique fingerprint.

Cite this